Immunotherapy for Head and Neck Cancer

Immunotherapy represents a new and effective approach to the treatment of head and neck cancer, based on immune system stimulation to fight cancer cells.

“Head and neck cancer” is a collective term that includes several different types of cancer, which include adenocarcinoma of the mouth, throat (pharynx) cancer, vocal apparatus (larynx), sinuses and nasal cavity cancer, and salivary glands cancer.

To date FDA has approved such drugs as Nivolumab (Opdivo), Pembrolizumab (Keytruda) and Cetuximab (Erbitux) for the treatment of head and neck cancer.

Currently, also other new immunotherapy drugs are being tested in clinical trials. Some of them showed impressive results.

Treatment of the head and neck area cancer depends on individual factors, including the exact location of the tumor, the stage and the general condition of the person. Methods of treatment include: surgery, radiation therapy and chemotherapy.

Immunotherapy medications are also used by our specialists in a personalized approach – precision medicine for the head and neck cancer treatment.

In order to determine what drugs are right for you in addition to standard protocols, our doctors may offer you a molecular genomic test to make up your tumor’s genetic profile.

Thanks to personalized treatment, there is 6 times more chances to reduce the growth of the tumor. These data are based on a study of 13,000 patients during 346 clinical trials.

⇒ Cancer Immunotherapy in Israel

⇒ Dr. Raanan Berger, Head of the Israeli Cancer Institute – What is personalized medicine and why is it important?

⇒ Cancer Pre-Screening Online in Israel